Prior to vaccine availability, RSV was a significant cause of illness and hospitalization in older adults in the U.S., ...

Older adults' immune systems naturally weaken with age, making them more susceptible to COVID-19, influenza (flu) and RSV. Here's what you need to know about these respiratory viruses and why ...

The respiratory syncytial virus (RSV) vaccine produced strong immune responses in older adults during its first two seasons of use, according to a new study.

The respiratory syncytial virus (RSV) vaccine triggered strong immune responses among people aged 60 years and older during ...

A vaccination programme introduced to protect babies and older adults against a dangerous respiratory disease has cut ...

A vaccination program has cut hospital admissions for a respiratory virus among older people in Scotland by nearly two-thirds ...

In adults aged 50 years and older, coadministration of respiratory syncytial virus vaccine mRNA-1345 plus seasonal influenza or COVID-19 vaccines was safe and noninferior to individual vaccine ...

Respiratory syncytial virus is a common, highly contagious illness that often causes mild upper respiratory symptoms, akin to a cold. In babies, particularly those with tiny airways, RSV can cause the ...

The NHS has begun inviting older people in Oxfordshire to receive their respiratory syncytial virus (RSV) vaccine.

Free RSV vaccines are being offered to thousands of older people. The invitations are being sent to residents in Hampshire ...

Respiratory syncytial virus (RSV) is known to cause considerable respiratory infection-related morbidity and mortality worldwide.1,2 Estimates published in 2022 from the UK highlight the ...